Oncological emergencies: Clinical importance and principles of management

European Journal of Cancer Care

Volumn 19, Issue 6, 2010, Pages 707-713

  Samphao, S ^a   Eremin, J M ^a   Eremin, O ^a,b  

^a LINCOLN COUNTY HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Emergencies; Hypercalcaemia; Neutropaenia; Spinal cord compression; Superior vena cava syndrome

Indexed keywords

EMERGENCY TREATMENT; HUMAN; HYPERCALCEMIA; METHODOLOGY; NEOPLASM; NEUTROPENIA; REVIEW; SPINAL CORD COMPRESSION; SUPERIOR CAVA VEIN SYNDROME;

EMERGENCY TREATMENT; HUMANS; HYPERCALCEMIA; NEOPLASMS; NEUTROPENIA; SPINAL CORD COMPRESSION; SUPERIOR VENA CAVA SYNDROME;

EID: 79955661720     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01091.x     Document Type: Review

References (25)

1. Allaqaband S., Solis J., Kazemi S. & Bajwa T. (2006) Endovascular treatment of peripheral vascular disease. Current Problem in Cardiology 31, 711-760.
2. Bodey G.P., Buckley M., Sathe Y.S. & Freireich E.J. (1966) Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of Internal Medicine 64, 328-340.
3. Cervantes A. & Chirivella I. (2004) Oncological emergencies. Annals of Oncology 15 (Suppl. 4), iv299-iv306.
4. Dosios T., Theakos N. & Chatziantoniou C. (2005) Cervical mediastinoscopy and anterior mediastinoscopy in superior vena cava obstruction. Chest 128, 1551-1556.
5. Freifeld A.G., Segal B.H., Baden L.R., Brown A.E., Casper C., Dubberke E., Gelfand M., Greene J.N., Ison M.G., Ito J.I., Karp J.E., Kaul D.R., King E., Marcucci G., Montoya J.G., Morris A., Rolston K. & Stuntebeck E. (2007) Prevention and Treatment of Cancer-related Infections [National Comprehensive Cancer Network website]. Available at: http://www.nccn.org/professionals/physician_gls/PDF/infections.pdf (accessed 7 December 2007).
6. Higdon M.L. & Higdon J.A. (2006) Treatment of oncologic emergencies. American Family Physician 74, 1873-1880.
7. Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., Feld R., Pizzo P.A., Rolston K.V., Shenep J.L. & Young L.S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases 34, 730-751.
8. Klastersky J., Paesmans M., Rubenstein E.B., Boyer M., Elting L., Feld R., Gallagher J., Herrstedt J., Rapoport B., Rolsion K. & Talcott J. (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. Journal of Clinical Oncology 18, 3038-3051.
9. Klimo P., Thompson C.J., Kestle J.R.W. & Schmidt M.H. (2005) A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-oncology 7, 64-76.
10. Loblaw D.A. & Laperriere N.J. (1998) Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. Journal of Clinical Oncology 16, 1613-1624.
11. Loblaw D.A., Perry J., Chambers A. & Laperriere N.J. (2005) Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the cancer care Ontario practice guidelines initiative's neuro-oncology disease site group. Journal of Clinical Oncology 23, 2028-2037.
12. Major P., Lortholary A., Hon J., Abdi E., Mills G., Menssen H.D., Yunus F., Bell R., Body J., Quebe-Fehling E. & Seaman J. (2001) Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Journal of Clinical Oncology 19, 558-567.
13. Patchell R., Tibbs P.A., Regine W.F., Payne R., Saris S., Kryscio R.J., Mohiuddin M. & Young B. (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. The Lancet 366, 643-648.
14. Paul M., Borok S., Fraser A., Vidal L., Cohen M. & Leibovici L. (2005) Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Cochrane Database Systematic Reviews 3, CD003914.
15. Pavlakis N., Schmidt R.L. & Stockler M. (2005) Bisphosphonates for breast cancer. Cochrane Database Systematic Reviews 3, CD003474.
16. Ross J.R., Saunders Y., Edmonds P.M., Patel S., Wonderling D., Normand C. & Broadley K. (2004) A systematic review of the role of bisphosphonates in metastatic disease. Health Technology Assessment 8, 1-176.
17. Rowell N.P. & Gleeson F.V. (2001) Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Systematic Reviews 4, CD001316.
18. Saunders Y., Ross J.R., Broadley K.E., Edmonds P.M. & Patel S. (2004) Systematic review of bisphosphonates for hypercalcaemia of malignancy. Palliative Medicine 18, 418-431.
19. Stanford W., Jolles H., Ell S. & Chiu L.C. (1987) Superior vena cava obstruction: a venographic classification. American Journal of Roentgenology 148, 259-262.
20. Stewart A.F. (2005) Clinical practice. Hypercalcemia associated with cancer. New England Journal of Medicine 352, 373-379.
21. Talcott J.A., Siegel R.D., Finberg R. & Goldman L. (1992) Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. Journal of Clinical Oncology 10, 316-322.
22. Thirlwell C. & Brock C. (2003) Emergencies in oncology. Clinical Medicine 3, 306-310.
23. Uberoi R. (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovascular Intervention Radiology 29, 319-322.
24. Vidal L., Paul M., Ben-Dor I., Pokroy E., Soares-Weiser K. & Leibovici L. (2004) Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients. Cochrane Database Systematic Reviews 4, CD003992.
25. Wilson L.D., Detterbeck F.C. & Yahalom J. (2007) Clinical practice. Superior vena cava syndrome with malignant causes. New England Journal of Medicine 356, 1862-1869.